Thrombocytopenia in Patients With Myelodysplastic Syndromes
Seminars in Hematology2010Vol. 47(3), pp. 274–280
Citations Over TimeTop 20% of 2010 papers
Related Papers
- → Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia(2011)124 cited
- → Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia?(2016)47 cited
- → Thrombocytopenia in Patients With Myelodysplastic Syndromes(2010)38 cited
- → Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?(2016)1 cited
- → Clinical Applications and Advances of Thrombopoietin Receptor Agonist(2014)